how were glp 1 agonists discovered Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review GLP-1 Agonists For Obesity In

Geliebter A

Arch Med Sci

491 By regulating appetite, insulin secretion, and lipid metabolism, GLP-1RAs have potential benefits in the treatment of NAFLD, NASH, and T2DM

For semaglutide alone, trials relating to cardiovascular disease (SELECT), kidney disease (FLOW) and heart failure (STEP) have announced positive results in the last 12 months

This molecule bore a striking resemblance to human glucagon-like peptide-1 (GLP-1), a hormone naturally produced in the gut that plays a crucial role in regulating blood sugar and appetite

Recently, the first approval for a dual-receptor agonist marks an important step in this development